OPEN END TURBO LONG - RESMED | Market Closed - Bid/Ask 17:13:45 07/06/2024 BST | After market 20:03:51 | |||
| 1.48 EUR | +5.71% |
|
1.46 | -1.35% |
| Current month | +35.92% | ||
| 1 month | -33.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 1.48 | +5.71% |
| 06/06/24 | 1.4 | -13.04% |
| 05/06/24 | 1.61 | +11.81% |
| 04/06/24 | 1.44 | +35.85% |
| 03/06/24 | 1.06 | +2.91% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 05:13 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG38MB |
| ISIN | DE000MG38MB0 |
| Date issued | 29/04/2024 |
| Strike | 196.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.4 € |
|---|---|
| Lowest since issue | 0.87 € |
| Spread | 0.04 € |
| Spread % | 2.63% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.6
USD
Average target price
218.7
USD
Spread / Average Target
+3.38%
- Stock Market
- Certificates
- Certificat